Targeting Of Somatic Hypermutation By immunoglobulin Enhancer And Enhancer-Like Sequences

• Jean-Marie Buerstedde ,

  * E-mail:brstdd@gmail.com (J-MB); david.schatz@yale.edu (DGS)

  Affiliation Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• Jukka Alinikula,

  Affiliations Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, United States of America, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• Hiroshi Arakawa,

  Affiliation IFOM-FIRC Institute of Molecular Oncology Foundation, Milano, Italy

  ⨯
• Jessica J. McDonald,

  Affiliation Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• David G. Schatz

  * E-mail:brstdd@gmail.com (J-MB); david.schatz@yale.edu (DGS)

  Affiliations Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, United States of America, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut, United States of America

  ⨯